Task Order 3: Nonclinical Toxicology Study of an Investigational Agent in Development for Anticancer Therapy

NIH RePORTER · NIH · N01 · $268 · view on reporter.nih.gov ↗

Abstract

The test agent is being considered for development as an anticancer therapeutic. The objective of this task was to characterize the target organ toxicities of an investigative agent that might move forward to clinical testing for anticancer activity. The information obtained from this investigation was used to identify drugs with the potential to treat cancer.

Key facts

NIH application ID: 10867249
Project number: 261201100028C-P00018-9999-1
Recipient: SRI INTERNATIONAL
Principal Investigator: TOUFAN PARMAN
Activity code: N01
Funding institute: NIH
Fiscal year: 2023
Award amount: $268
Award type: —
Project period: 2011-07-01 → 2016-06-30